isoproterenol has been researched along with Panic Attacks in 11 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the effects of beta-adrenergic stimulation on R and T amplitude variability in panic disorder patients by infusing the beta-adrenergic agonist isoproterenol in 6 panic disorder patients and 11 normal subjects." | 9.12 | Exaggerated beat-to-beat R amplitude variability in patients with panic disorder after intravenous isoproterenol. ( Bär, KJ; Chokka, P; Pohl, R; Tancer, M; Yeragani, VK, 2007) |
| " We examined the effects of sympathetic stimulation on QT interval variability in panic disorder patients by infusing the ss-adrenergic agonist isoproterenol in 6 panic disorder patients and 11 normal subjects." | 7.71 | QT interval variability in panic disorder patients after isoproterenol infusions. ( K Yeragani, V; Pohl, R, 2001) |
| "Paroxetine was administered to all of the panic patients for 12 weeks." | 5.35 | beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder. ( Kang, EH; Kim, KJ; Lee, IS; Yu, BH, 2008) |
| "We examined the effects of beta-adrenergic stimulation on R and T amplitude variability in panic disorder patients by infusing the beta-adrenergic agonist isoproterenol in 6 panic disorder patients and 11 normal subjects." | 5.12 | Exaggerated beat-to-beat R amplitude variability in patients with panic disorder after intravenous isoproterenol. ( Bär, KJ; Chokka, P; Pohl, R; Tancer, M; Yeragani, VK, 2007) |
| "This study was conducted on patients with panic disorder (PD) to examine the gender differences in the pathophysiology of PD by evaluating and comparing the value of CD(25)/wt, the chronotropic 25 dose of isoproterenol (CD(25)) divided by the body weight, which reflects the in vivo index of beta-adrenergic receptor sensitivity." | 5.11 | Differences in beta-adrenergic receptor sensitivity between women and men with panic disorder. ( Kim, YR; Min, SK; Yu, BH, 2004) |
| "Lymphocyte beta adrenoreceptor density and affinity, basal lymphocyte cAMP level, and isoproterenol-stimulated cAMP generation were measured in 27 untreated outpatients with panic disorder with agoraphobia and 24 healthy comparison subjects." | 5.07 | Evidence that decreased function of lymphocyte beta adrenoreceptors reflects regulatory and adaptive processes in panic disorder with agoraphobia. ( Carter, CS; Gietzen, DW; Maddock, RJ; Magliozzi, JR, 1993) |
| "Plasma catecholamines and hemodynamics were examined in response to intravenous glucagon, yohimbine, and trimethaphan in 11 patients with pseudopheochromocytoma and a comparison group of nine normotensive and five hypertensive volunteers." | 3.74 | Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma. ( Bentho, O; Eisenhofer, G; Geraci, MF; Goldstein, DS; Holmes, C; Pacak, K; Pechnik, S; Saleem, A; Sharabi, Y, 2007) |
| " We examined the effects of sympathetic stimulation on QT interval variability in panic disorder patients by infusing the ss-adrenergic agonist isoproterenol in 6 panic disorder patients and 11 normal subjects." | 3.71 | QT interval variability in panic disorder patients after isoproterenol infusions. ( K Yeragani, V; Pohl, R, 2001) |
| "Paroxetine was administered to all of the panic patients for 12 weeks." | 1.35 | beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder. ( Kang, EH; Kim, KJ; Lee, IS; Yu, BH, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalsa, SS | 1 |
| Feinstein, JS | 1 |
| Li, W | 1 |
| Feusner, JD | 1 |
| Adolphs, R | 1 |
| Hurlemann, R | 1 |
| Kim, YR | 1 |
| Min, SK | 1 |
| Yu, BH | 2 |
| Khurana, RK | 1 |
| Yeragani, VK | 2 |
| Pohl, R | 3 |
| Bär, KJ | 1 |
| Chokka, P | 1 |
| Tancer, M | 1 |
| Sharabi, Y | 1 |
| Goldstein, DS | 1 |
| Bentho, O | 1 |
| Saleem, A | 1 |
| Pechnik, S | 1 |
| Geraci, MF | 1 |
| Holmes, C | 1 |
| Pacak, K | 1 |
| Eisenhofer, G | 1 |
| Lee, IS | 1 |
| Kim, KJ | 1 |
| Kang, EH | 1 |
| Srinivasan, K | 1 |
| Balon, R | 1 |
| Ramesh, C | 1 |
| Berchou, R | 1 |
| Maddock, RJ | 2 |
| Gietzen, DW | 2 |
| Goodman, TA | 1 |
| Carter, CS | 1 |
| Magliozzi, JR | 1 |
| K Yeragani, V | 1 |
| Le Mellédo, JM | 1 |
| Arthur, H | 1 |
| Dalton, J | 1 |
| Woo, C | 1 |
| Lipton, N | 1 |
| Bellavance, F | 1 |
| Koszycki, D | 1 |
| Boulenger, JP | 1 |
| Bradwejn, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Gabapentin Treatment of Postural Tachycardia Syndrome (PoTS): a Pilot Study[NCT04345432] | 10 participants (Actual) | Interventional | 2014-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for isoproterenol and Panic Attacks
| Article | Year |
|---|---|
Differences in beta-adrenergic receptor sensitivity between women and men with panic disorder.
Topics: Adrenergic beta-Agonists; Adult; Catecholamines; Dose-Response Relationship, Drug; Female; Heart Rat | 2004 |
Experimental induction of panic-like symptoms in patients with postural tachycardia syndrome.
Topics: Adult; Cardiotonic Agents; Diagnosis, Differential; Female; Humans; Hypotension, Orthostatic; Isopro | 2006 |
Exaggerated beat-to-beat R amplitude variability in patients with panic disorder after intravenous isoproterenol.
Topics: Adrenergic beta-Agonists; Adult; Analysis of Variance; Electrocardiography; Female; Heart Conduction | 2007 |
Evidence that decreased function of lymphocyte beta adrenoreceptors reflects regulatory and adaptive processes in panic disorder with agoraphobia.
Topics: Adult; Agoraphobia; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Cyclic AMP; Double- | 1993 |
The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiovascular Physiol | 2001 |
6 other studies available for isoproterenol and Panic Attacks
| Article | Year |
|---|---|
Panic Anxiety in Humans with Bilateral Amygdala Lesions: Pharmacological Induction via Cardiorespiratory Interoceptive Pathways.
Topics: Adrenergic beta-Agonists; Adult; Afferent Pathways; Amygdala; Female; Heart; Humans; Interoception; | 2016 |
Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma.
Topics: Adrenal Glands; Adult; Baroreflex; Blood Pressure Monitoring, Ambulatory; Epinephrine; Female; Gluca | 2007 |
beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder.
Topics: Acute Disease; Adult; Ambulatory Care; Biomarkers; Control Groups; Cyclic AMP; Female; Humans; Isopr | 2008 |
Effects of isoproterenol infusions on heart rate variability in patients with panic disorder.
Topics: Adrenergic beta-Agonists; Adult; Anxiety; Female; Heart Rate; Humans; Infusions, Intravenous; Isopro | 1995 |
Decreased lymphocyte beta-adrenoreceptor function correlates with less agoraphobia and better outcome in panic disorder.
Topics: Adult; Agoraphobia; Behavior Therapy; Combined Modality Therapy; Down-Regulation; Female; Humans; Is | 1993 |
QT interval variability in panic disorder patients after isoproterenol infusions.
Topics: Adrenergic beta-Agonists; Adult; Analysis of Variance; Electrocardiography; Female; Heart Rate; Huma | 2001 |